Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Vorinostat (V), bortezomib (B), doxorubicin (Dox) and dexamethasone (Dex, VBDD) in relapsed or refractory multiple myeloma patients (pts): results of an open, non-comparative, phase I/II investigator initiated trial (IIT)

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Clinical Lymphoma Myeloma and Leukemia
          Clinical Lymphoma Myeloma and Leukemia
          Elsevier BV
          21522650
          September 2015
          September 2015
          : 15
          : e276-e277
          Article
          10.1016/j.clml.2015.07.572
          © 2015

          Comments

          Comment on this article